CRISPR Therapeutics AG

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

CRSP

organization

Jurisdiction: CHLegal Form: MVII

ACTIVE

LEI: 506700O6IRRIQLT3W370SIC: 2836Active: 2019–2019

Also known as: CRISPR THERAPEUTICS AG, CRISPR Therapeutics AG

SEC Insider

$652.7M

1,436 transactions

Summary

CRISPR Therapeutics AG (CRSP) is an organization. Lobbying activity focuses on Medical/Disease Research/Clinical Labs.

Top Lobbying Issues

Legal entity: GLEIF

SEC filings: SEC EDGAR

Activity data: SEC EDGAR